NCT05126004View on ClinicalTrials.gov

AZA Combined With NAC for PIT After HSCT

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2026

Conditions
Thrombocytopenia, IsolatedStem Cell Transplant Complications
Interventions
DRUG

Azacitidine

28 days for one cycle, evaluation post 3 cycles of treatment. Continue if response exists, otherwise, quit the trial and seek for other therapies.

DRUG

N Acetyl L Cysteine

28 days for one cycle, evaluation post 3 cycles of treatment. Continue if response exists, otherwise, quit the trial and seek for other therapies.

Trial Locations (1)

215000

The first affiliated hospital of Soochow University, Suzhou

All Listed Sponsors
lead

The First Affiliated Hospital of Soochow University

OTHER